Somnomed Ltd (SOM) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.083x

Based on the latest financial reports, Somnomed Ltd (SOM) has a cash flow conversion efficiency ratio of 0.083x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$4.15 Million ≈ $2.93 Million USD) by net assets (AU$50.04 Million ≈ $35.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SOM company net worth for the company's overall valuation and market capitalisation.

Somnomed Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Somnomed Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Somnomed Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Somnomed Ltd ranked by their cash flow conversion efficiency. Explore Somnomed Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Hansol Csn
KO:009180
0.030x
International Conveyors Limited
NSE:INTLCONV
-0.015x
Athanase Innovation AB
ST:ATIN
-0.077x
Sachem Capital Corp
NYSE MKT:SACH
-0.017x
Acrivon Therapeutics, Inc. Common Stock
NASDAQ:ACRV
-0.096x
Dsr Wire
KO:069730
0.007x
Bina Puri Holdings Bhd
KLSE:5932
-0.332x
E& Corporation CO. LTD
KQ:066980
0.084x

Annual Cash Flow Conversion Efficiency for Somnomed Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of Somnomed Ltd from 2004 to 2025. View SOM stock price and chart for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$46.39 Million
≈ $32.82 Million
AU$7.78 Million
≈ $5.51 Million
0.168x +219.29%
2024-06-30 AU$45.02 Million
≈ $31.86 Million
AU$-6.33 Million
≈ $-4.48 Million
-0.141x +18.79%
2023-06-30 AU$22.40 Million
≈ $15.85 Million
AU$-3.88 Million
≈ $-2.75 Million
-0.173x -359.08%
2022-06-30 AU$27.79 Million
≈ $19.66 Million
AU$1.86 Million
≈ $1.31 Million
0.067x -20.55%
2021-06-30 AU$32.16 Million
≈ $22.75 Million
AU$2.71 Million
≈ $1.91 Million
0.084x -45.14%
2020-06-30 AU$33.84 Million
≈ $23.94 Million
AU$5.19 Million
≈ $3.67 Million
0.153x +141.74%
2019-06-30 AU$17.82 Million
≈ $12.61 Million
AU$-6.55 Million
≈ $-4.63 Million
-0.367x -27.15%
2018-06-30 AU$32.77 Million
≈ $23.19 Million
AU$-9.47 Million
≈ $-6.70 Million
-0.289x -233.80%
2017-06-30 AU$30.95 Million
≈ $21.90 Million
AU$-2.68 Million
≈ $-1.90 Million
-0.087x -234.43%
2016-06-30 AU$32.69 Million
≈ $23.13 Million
AU$2.11 Million
≈ $1.49 Million
0.064x +671.80%
2015-06-30 AU$21.51 Million
≈ $15.22 Million
AU$-242.22K
≈ $-171.39K
-0.011x +82.09%
2014-06-30 AU$12.57 Million
≈ $8.89 Million
AU$-790.41K
≈ $-559.26K
-0.063x -227.22%
2013-06-30 AU$11.57 Million
≈ $8.19 Million
AU$572.00K
≈ $404.73K
0.049x +52.14%
2012-06-30 AU$8.92 Million
≈ $6.31 Million
AU$289.78K
≈ $205.04K
0.032x +16.97%
2011-06-30 AU$6.22 Million
≈ $4.40 Million
AU$172.68K
≈ $122.18K
0.028x -65.99%
2010-06-30 AU$5.65 Million
≈ $4.00 Million
AU$461.46K
≈ $326.51K
0.082x +126.86%
2009-06-30 AU$4.33 Million
≈ $3.07 Million
AU$-1.32 Million
≈ $-932.16K
-0.304x +13.64%
2008-06-30 AU$6.01 Million
≈ $4.25 Million
AU$-2.12 Million
≈ $-1.50 Million
-0.352x +41.01%
2007-06-30 AU$3.91 Million
≈ $2.77 Million
AU$-2.34 Million
≈ $-1.65 Million
-0.597x +48.50%
2006-06-30 AU$3.23 Million
≈ $2.29 Million
AU$-3.75 Million
≈ $-2.65 Million
-1.159x -143.07%
2005-06-30 AU$7.20 Million
≈ $5.10 Million
AU$-3.43 Million
≈ $-2.43 Million
-0.477x -128.41%
2004-06-30 AU$-160.08K
≈ $-113.26K
AU$-268.63K
≈ $-190.07K
1.678x --

About Somnomed Ltd

AU:SOM Australia Medical Devices
Market Cap
$52.71 Million
AU$74.49 Million AUD
Market Cap Rank
#21793 Global
#759 in Australia
Share Price
AU$0.34
Change (1 day)
-2.86%
52-Week Range
AU$0.32 - AU$0.89
All Time High
AU$3.28
About

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product desig… Read more